Routine clinical care for chronic immune thrombocytopenia purpura in Denmark, 2009-2015.

Conclusion: We found that corticosteroids, IVIG, and rituximab are common first- choice of ITP drugs. Bleeding events occurred in nearly one third of treated patients in the year before cITP diagnosis and in 5% of the treatment-naïve patients. A substantial number of patients do not need treatment during the first 6-12 months. However, some of these patients will subsequently need treatment as the disease may worsen, indicating the need for continuous follow-up of these patients. PMID: 31674882 [PubMed - in process]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research